1 --;The Cholinergic Hypothesis a Generation Later: Perspectives Gained on the Use and Integration of Animal Models --;2 --;Patterns of Cognitive Decline in the Aged Rhesus Monkey --;3 --;Cholinergic Lesions as a Model of Alzheimer's Disease: Effects of Nerve Growth Factor --;4 --;The Immunolesioned Animal as a Model of Transmitter Dysfunction --;5 --;An Intracerebral Tumor Necrosis Factor-? Infusion Model for Inflammation in Alzheimer's Disease --;6 --;The Senescence-Accelerated Mouse as a Possible Animal Model of Senile Dementia --;7 --;Transgenic Mice Overexpressing Presenilin cDNAs: Phenotype and Utility in the Modeling of Alzheimer's Disease --;8 --;Intervention Strategies for Degeneration of Dopamine Neurons in Parkinsonism: Optimizing Behavioral Assessment of Outcome --;9 --;Development of Behavioral Outcome Measures for Preclinical Parkinson's Research --;10 --;Behavioral Assessment in the Unilateral Dopamine-Depleted Marmoset --;11 --;Molecules for Neuroprotection and Regeneration in Animal Models of Parkinson's Disease --;12 --;Antisense Knockdown of Dopamine Receptors --;13 --;Is Trophic Factor Gene Disruption a 'Knockout' Model for Parkinson's Disease? --;14 --;Operant Analysis of Striatal Dysfunction --;15 --;Intrastriatal Injections of Quinolinic Acid as a Model for Developing Neuroprotective Strategies in Huntington's Disease --;16 --;Systemic Administration of 3-Nitropropionic Acid: A New Model of Huntington's Disease in Rat --;17 --;Replicating Huntington Disease's Phenotype in Nonhuman Primates --;18 --;Transgenic Mouse Models of Huntington's Disease --;19 --;Rigid Indentation Models of Traumatic Brain Injury in the Rat --;20 --;Rodent Ischemia Models of Embolism and Ligation of the Middle Cerebral Artery: Clinical Relevance to Treatment Strategies of Stroke --;21 --;A Primate Model of Hypertensive Cerebrovascular Disease --;22 --;Nictotinic Therapeutics for Tourette Syndrome and Other Neuropsychiatric Disorders: From Laboratory to Clinic --;23 --;Neural Grafting for Parkinson's and Huntington's Disease --;24 --;Future Prospects of Gene Therapy for Treating CNS Diseases.
SUMMARY OR ABSTRACT
Text of Note
Prominent experimentalists critically review the animal models widely used in developing powerful new therapies for central nervous system diseases.
TOPICAL NAME USED AS SUBJECT
Aging -- physiology.
Alzheimer Disease -- physiopathology.
Central nervous system -- Diseases -- Animal models.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC361
Book number
.
E358
2000
PERSONAL NAME - PRIMARY RESPONSIBILITY
edited by Dwaine F. Emerich, Reginald L. Dean III, Paul R. Sanberg.